“The solid Q1 performance underscores the strength of the formidable combination of brand and distribution reach in terms of geography and demography that SBI Life has. The management remained confident about delivering growth and maintaining margin trajectory. With its distribution channels firing on all cylinders, expanding product offerings and increasing acceptance, we expect robust growth to continue in FY23 and beyond,” the brokerage said.
Valiant Laboratories IPO fully subscribed on Day 3. Check GMP & other details
The offer, which is priced at Rs 133-140 apiece, is completely a fresh equity issue of 1.08 crore shares. Investors can bid for a minimum
September 29, 2023